Evidence map›Paper›PMID 37446148›Full record

ArticleInternational journal of molecular sciences2023

Pathophysiology of Cerebellar Degeneration in Mitochondrial Disorders: Insights from the

Miguel Fernández de la Torre, Carmen Fiuza-Luces, Sara Laine-Menéndez, Aitor Delmiro, Joaquín Arenas, Miguel Ángel Martín, Alejandro Lucia, María Morán

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Miguel Fernández de la TorreMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital '12 de Octubre' ('imas12'), 28041 Madrid, Spain.
Carmen Fiuza-LucesMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital '12 de Octubre' ('imas12'), 28041 Madrid, Spain.
Sara Laine-MenéndezMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital '12 de Octubre' ('imas12'), 28041 Madrid, Spain.
Aitor DelmiroMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital '12 de Octubre' ('imas12'), 28041 Madrid, Spain.
Joaquín ArenasMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital '12 de Octubre' ('imas12'), 28041 Madrid, Spain.
Miguel Ángel MartínMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital '12 de Octubre' ('imas12'), 28041 Madrid, Spain.ORCID 0000-0003-4741-772X
Alejandro LuciaFaculty of Sports Sciences, European University of Madrid, 28670 Madrid, Spain.
María MoránMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital '12 de Octubre' ('imas12'), 28041 Madrid, Spain.ORCID 0000-0001-5408-7189
Research Institute Hospital 12 de Octubre · ESCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable · ES

Funding

European Union PI17/00093European Union PI20/00147Instituto de Salud Carlos III PI20/00147Instituto de Salud Carlos III PI71/00093
6 · The paper itself

Abstract

By means of a proteomic approach, we assessed the pathways involved in cerebellar neurodegeneration in a mouse model

Indexed as

Cerebellar DiseasesMitochondrial DiseasesNeurodegenerative DiseasesAnimalsCerebellumMaleMiceProteomicsataxiacomplex IGABAglutamateHarlequin mouselong-term depressionmitochondrial diseasesOXPHOS disorders

Identifiers

PMID37446148
PMCPMC10341771
OpenAlexW4382752627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.